Uterine cancer — also called endometrial cancer — most often announces itself with post-menopausal bleeding, a symptom that should always be evaluated promptly. Dr. Dipanwita Banerjee, Senior Consultant Gynaecological Oncologist at CNCI, manages uterine cancer from risk awareness through staging surgery and robotic treatment.
Whatever stage you are at — a risk factor like PCOS or obesity, post-menopausal bleeding you haven't had checked, a confirmed diagnosis, or planning for fertility — find your situation below to see how Dr. Banerjee approaches it.
Uterine cancer, most commonly endometrial cancer, develops in the lining of the uterus. It is one of the five gynaecological cancers Dr. Banerjee treats, and — because its most common symptom, post-menopausal bleeding, tends to appear relatively early — it is often diagnosed at an earlier stage than ovarian cancer.
As with ovarian and vulval cancer, there is currently no routine population screening test for uterine cancer. Prompt evaluation of any post-menopausal bleeding, and awareness of metabolic risk factors, are the most important tools for early detection — and Dr. Banerjee's practice covers the complete pathway from risk assessment through staging surgery and long-term follow-up.
Because uterine cancer has no routine screening test, awareness of risk factors and prompt evaluation of bleeding symptoms carry most of the weight. Dr. Banerjee's approach follows where a woman actually is — from understanding metabolic risk with no symptoms, through evaluating bleeding, to staging surgery and life after treatment.
Uterine cancer has no routine population screening test, which makes understanding personal risk factors one of the few tools available before symptoms appear.
Both conditions are linked to prolonged, unopposed oestrogen exposure — a known driver of changes in the uterine lining.
Polycystic ovary syndrome is a recognised risk factor, and because it affects younger women, some patients are diagnosed at a reproductive age.
Unlike cervical cancer, there is no population screening test for uterine cancer — awareness of risk factors and symptoms carries the weight instead.
Post-menopausal bleeding is the hallmark symptom of uterine cancer and should never be dismissed as a normal part of ageing — it warrants prompt, not delayed, evaluation.
Any vaginal bleeding after menopause is the most common symptom of uterine cancer and should be evaluated promptly rather than watched.
Clinical evaluation, ultrasound and endometrial sampling to investigate the bleeding and determine whether cancer is present.
Because this symptom tends to appear relatively early in the disease course, prompt evaluation often means an earlier-stage, more treatable diagnosis.
Uterine cancer management centres on accurate surgical staging, with robotic techniques offering a minimally invasive option for many patients.
Specific expertise in the staging surgery used to manage uterine (endometrial) cancer, as part of her broader work in ovarian, uterine and other gynaecological malignancies.
Fellowship-trained at Roswell Park Comprehensive Cancer Centre, New York, in robotic procedures for endometrial cancer — offering faster recovery and reduced surgical trauma compared to open surgery.
As In-charge of the Department of Surgical Oncology (Gynaecology) at CNCI, surgical staging is coordinated with chemotherapy and radiation input from other specialists as each case requires.
Because PCOS is a recognised risk factor, some women who develop uterine cancer are of reproductive age at diagnosis — making fertility planning a real part of care for this condition.
For women of reproductive age — including those with PCOS-related risk — sensitive counselling on fertility-sparing surgical options where the disease stage allows it.
Given the established links to obesity, diabetes and PCOS, ongoing awareness of these risk factors is incorporated into follow-up care.
A defined surveillance schedule after treatment to check for recurrence early, when it is most treatable.
"Committed to bringing the highest standard of gynaecological cancer care — with science, skill, and deep compassion — to every patient who trusts me with their care."